Jared S. Hopkins - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jared S. Hopkins's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jared S. Hopkins

Jared S. Hopkins

Verified

Pharma Reporter, The Wall Street Journal

New York

Doesn’t Cover

Anything which I am Not well-read Enough To cover

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

Content

Total articles 1347

  • Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results

    By Jared S. Hopkins Verified, Brianna Abbott Verified| The Wall Street Journal Verified The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs closer to patients seeking to lose weight.

    By Jared S. Hopkins Verified, Brianna Abbott Verified · The Wall Street Journal

    Apr. 17, 2025

  • Exclusive | Drug Development Is Slowing Down After Cuts at the FDA

    By Jared S. Hopkins Verified| The Wall Street Journal Verified Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug Administration. Significant delays in the FDA’s core functions—such as approving amendments to clinical trials and guiding companies through processes for drug approval—are hindering the ability to develop drugs, say industry officials.

    By Jared S. Hopkins Verified · The Wall Street Journal

    Apr. 17, 2025

  • Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results

    By Jared S. Hopkins Verified, Brianna Abbott Verified| The Wall Street Journal Verified The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs closer to patients seeking to lose weight.

    By Jared S. Hopkins Verified, Brianna Abbott Verified · The Wall Street Journal

    Apr. 17, 2025

As seen in

Company Info

The Wall Street Journal

The Wall Street Journal (WSJ) is a prominent American daily newspaper, established on July 8, 1889. It specializes in business, finance, and global news, making it one of the most influential newspapers in the U.S. The WSJ is owned by Dow Jones & Company, a subsidiary of News Corp, which acquired it in 2007. The WSJ publishes six days a week and offers both print and digital subscriptions. It provides comprehensive coverage of various topics, including business, finance, politics, and lifestyle. The newspaper features a well-regarded opinion section and includes special sections like Market Data, Personal Finance, and Life & Arts. With a readership that includes financial professionals, business leaders, and individual investors, the WSJ is a key resource for those seeking insights into market trends and economic policies. The WSJ has received numerous accolades for its journalism, including 39 Pulitzer Prizes, and has a significant digital presence with over 3 million digital subscribers.

New York, New York, United States

+1 609-520-4185

Founded: 1889